People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vireo Growth Inc. | — | Other | Series C | $197.6M | $9.6M | 2020 |
| Vireo Health, Inc. | — | Pharmaceuticals | Series B | $16.1M | $547.2M | 2018 |
Stephen Dahmer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Dahmer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kyle Kingsley | 2 | 5 |
| Amber Shimpa | 2 | 4 |
| Aaron Hoffnung | 2 | 3 |
| Eric Greenbaum | 2 | 2 |
| Bruce Linton | 1 | 4 |
| John Mazarakis | 1 | 4 |
| Joshua Rosen | 1 | 3 |
| Ross Hussey | 1 | 3 |
| John Heller | 1 | 3 |
| Michael Schroeder | 1 | 2 |
| Judd Nordquist | 1 | 2 |
| Josh Rosen | 1 | 2 |
| Shaun Nugent | 1 | 2 |
| Jennifer Duey | 1 | 1 |
| Chelsea Grayson | 1 | 1 |
| Ari Hoffnung | 1 | 1 |
| John E. Mazarakis | 1 | 1 |
| Victor E. Mancebo | 1 | 1 |
| Judd E. Nordquist | 1 | 1 |
| Patrick Peters | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.